Wednesday afternoon, Sen. Bernie Sanders tweeted the following:
It’s not a mystery why drug companies raise their prices to obscene levels. Just look at the multi-million dollar paychecks their CEOs get.
— Bernie Sanders (@SenSanders) August 24, 2016
During his campaign for the Democratic presidential nomination, Sanders often made an issue of high drug prices. And recently, Sanders noted that the price of epinephrine injectors, a.k.a. “Epi-Pens,” which millions of Americans depend on as a lifesaving measure in case they have an allergic reaction, appear to have been artificially inflated:
There’s no reason an EpiPen, which costs Mylan just a few dollars to make, should cost families more than $600. https://t.co/rVWUlMxD0Q
— Bernie Sanders (@SenSanders) August 18, 2016
Just this morning, Bloomberg reported the following (as noted by Geoffrey Norman in THE WEEKLY STANDARD):
It would seem that Sanders’s tweet about CEO salaries is a pointed message directed squarely at his Democratic colleague in the Senate.
